Monetary Management Group Inc. Acquires 75 Shares of Thermo Fisher Scientific Inc (TMO)

Monetary Management Group Inc. grew its holdings in Thermo Fisher Scientific Inc (NYSE:TMO) by 0.6% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 12,150 shares of the medical research company’s stock after purchasing an additional 75 shares during the period. Monetary Management Group Inc.’s holdings in Thermo Fisher Scientific were worth $2,120,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of TMO. Proficio Capital Partners LLC raised its holdings in shares of Thermo Fisher Scientific by 71.5% in the first quarter. Proficio Capital Partners LLC now owns 607 shares of the medical research company’s stock valued at $105,000 after purchasing an additional 253 shares during the last quarter. Chicago Partners Investment Group LLC acquired a new stake in shares of Thermo Fisher Scientific in the second quarter valued at approximately $108,000. Cribstone Capital Management LLC raised its holdings in shares of Thermo Fisher Scientific by 8.7% in the second quarter. Cribstone Capital Management LLC now owns 625 shares of the medical research company’s stock valued at $109,000 after purchasing an additional 50 shares during the last quarter. Sharkey Howes & Javer raised its holdings in shares of Thermo Fisher Scientific by 1.0% in the first quarter. Sharkey Howes & Javer now owns 733 shares of the medical research company’s stock valued at $113,000 after purchasing an additional 7 shares during the last quarter. Finally, Shine Investment Advisory Services Inc. acquired a new stake in shares of Thermo Fisher Scientific in the second quarter valued at approximately $113,000. Institutional investors own 83.61% of the company’s stock.

In other Thermo Fisher Scientific news, VP Peter E. Hornstra sold 3,894 shares of Thermo Fisher Scientific stock in a transaction on Tuesday, September 5th. The shares were sold at an average price of $185.18, for a total transaction of $721,090.92. Following the completion of the transaction, the vice president now directly owns 19,751 shares of the company’s stock, valued at $3,657,490.18. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, VP Seth H. Hoogasian sold 4,140 shares of Thermo Fisher Scientific stock in a transaction on Monday, August 28th. The stock was sold at an average price of $177.80, for a total transaction of $736,092.00. Following the transaction, the vice president now directly owns 25,518 shares of the company’s stock, valued at $4,537,100.40. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 22,738 shares of company stock valued at $4,021,512. Company insiders own 0.49% of the company’s stock.

Thermo Fisher Scientific Inc (NYSE TMO) opened at $193.71 on Friday. The company has a current ratio of 1.26, a quick ratio of 0.81 and a debt-to-equity ratio of 0.78. Thermo Fisher Scientific Inc has a 52-week low of $139.07 and a 52-week high of $201.20. The company has a market cap of $77,524.10, a price-to-earnings ratio of 21.29, a price-to-earnings-growth ratio of 1.77 and a beta of 1.08.

Thermo Fisher Scientific (NYSE:TMO) last released its quarterly earnings data on Wednesday, October 25th. The medical research company reported $2.31 EPS for the quarter, topping the Zacks’ consensus estimate of $2.24 by $0.07. Thermo Fisher Scientific had a net margin of 11.73% and a return on equity of 15.94%. The firm had revenue of $5.12 billion during the quarter, compared to analysts’ expectations of $5.03 billion. During the same period in the previous year, the business posted $2.03 earnings per share. The company’s revenue for the quarter was up 13.9% compared to the same quarter last year. equities analysts predict that Thermo Fisher Scientific Inc will post 9.36 EPS for the current year.

A number of research firms have recently issued reports on TMO. Zacks Investment Research downgraded shares of Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a report on Monday, October 30th. Leerink Swann reiterated a “buy” rating on shares of Thermo Fisher Scientific in a report on Monday, October 30th. Jefferies Group LLC reiterated a “hold” rating and issued a $195.00 price objective on shares of Thermo Fisher Scientific in a report on Thursday, September 28th. Deutsche Bank AG set a $226.00 price objective on shares of Thermo Fisher Scientific and gave the company a “buy” rating in a report on Thursday, October 26th. Finally, BidaskClub downgraded shares of Thermo Fisher Scientific from a “strong-buy” rating to a “buy” rating in a report on Monday, July 31st. One investment analyst has rated the stock with a hold rating and sixteen have given a buy rating to the stock. The company has a consensus rating of “Buy” and an average target price of $205.71.

WARNING: “Monetary Management Group Inc. Acquires 75 Shares of Thermo Fisher Scientific Inc (TMO)” was published by Community Financial News and is the property of of Community Financial News. If you are reading this piece on another site, it was stolen and republished in violation of United States & international trademark & copyright legislation. The correct version of this piece can be accessed at https://www.com-unik.info/2017/11/05/monetary-management-group-inc-acquires-75-shares-of-thermo-fisher-scientific-inc-tmo.html.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

What are top analysts saying about Thermo Fisher Scientific Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Thermo Fisher Scientific Inc and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit